These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

935 related items for PubMed ID: 17646603

  • 1. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    Arch Intern Med; 2007 Jul 23; 167(14):1493-502. PubMed ID: 17646603
    [Abstract] [Full Text] [Related]

  • 2. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J.
    Am Heart J; 2004 Jul 23; 148(1):43-51. PubMed ID: 15215791
    [Abstract] [Full Text] [Related]

  • 3. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    J Am Coll Cardiol; 2007 Aug 21; 50(8):768-77. PubMed ID: 17707182
    [Abstract] [Full Text] [Related]

  • 4. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2008 Oct 21; 156(4):662-73. PubMed ID: 18926148
    [Abstract] [Full Text] [Related]

  • 5. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Coordinators.
    J Card Fail; 2007 Nov 21; 13(9):722-31. PubMed ID: 17996820
    [Abstract] [Full Text] [Related]

  • 6. Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Nunez E, Yancy CW, Young JB.
    Circ Heart Fail; 2008 May 21; 1(1):50-7. PubMed ID: 19808270
    [Abstract] [Full Text] [Related]

  • 7. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF).
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    Am J Cardiol; 2009 Jul 01; 104(1):107-15. PubMed ID: 19576329
    [Abstract] [Full Text] [Related]

  • 8. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, Gheorghiade M, O'Connor CM, Sun JL, Yancy CW, Young JB, Fonarow GC.
    Am Heart J; 2007 Aug 01; 154(2):277.e1-8. PubMed ID: 17643576
    [Abstract] [Full Text] [Related]

  • 9. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry.
    Fonarow GC, Yancy CW, Heywood JT, ADHERE Scientific Advisory Committee, Study Group, and Investigators.
    Arch Intern Med; 2005 Jul 11; 165(13):1469-77. PubMed ID: 16009861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ, Greaney K, Arai L, Brenner A, Carroll KC, Howerton NM, Lee M, Pada L, Tseng M, Maisel AS.
    Crit Pathw Cardiol; 2008 Sep 11; 7(3):153-72. PubMed ID: 18791404
    [Abstract] [Full Text] [Related]

  • 13. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Pieper K, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    Arch Intern Med; 2008 Apr 28; 168(8):847-54. PubMed ID: 18443260
    [Abstract] [Full Text] [Related]

  • 14. Predictors of delivery of hospital-based heart failure patient education: a report from OPTIMIZE-HF.
    Albert NM, Fonarow GC, Abraham WT, Chiswell K, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB.
    J Card Fail; 2007 Apr 28; 13(3):189-98. PubMed ID: 17448416
    [Abstract] [Full Text] [Related]

  • 15. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry).
    Young JB, Abraham WT, Albert NM, Gattis Stough W, Gheorghiade M, Greenberg BH, O'Connor CM, She L, Sun JL, Yancy CW, Fonarow GC, OPTIMIZE-HF Investigators and Coordinators.
    Am J Cardiol; 2008 Jan 15; 101(2):223-30. PubMed ID: 18178411
    [Abstract] [Full Text] [Related]

  • 16. Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF.
    Fonarow GC.
    Rev Cardiovasc Med; 2004 Jan 15; 5 Suppl 1():S45-54. PubMed ID: 15184838
    [Abstract] [Full Text] [Related]

  • 17. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Levy PD, Nandyal D, Welch RD, Sun JL, Pieper K, Ghali JK, Fonarow GC, Gheorghiade M, O'Connor CM.
    Am Heart J; 2010 Feb 15; 159(2):222-230.e2. PubMed ID: 20152220
    [Abstract] [Full Text] [Related]

  • 18. Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Coordinators.
    Am Heart J; 2007 Jan 15; 153(1):82.e1-11. PubMed ID: 17174643
    [Abstract] [Full Text] [Related]

  • 19. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
    Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC, Peterson ED, Get With The Guidelines Steering Committee.
    J Am Coll Cardiol; 2009 Feb 03; 53(5):416-22. PubMed ID: 19179199
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.